Renaissance Technologies LLC Buys 30,800 Shares of NanoViricides, Inc. (NYSE:NNVC)

Renaissance Technologies LLC raised its stake in NanoViricides, Inc. (NYSE:NNVC) by 26.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,700 shares of the company’s stock after acquiring an additional 30,800 shares during the quarter. Renaissance Technologies LLC owned about 1.04% of NanoViricides worth $208,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Virtu Financial LLC bought a new stake in shares of NanoViricides in the fourth quarter worth about $91,000. 10.30% of the stock is currently owned by institutional investors.

NanoViricides Stock Performance

Shares of NNVC opened at $1.31 on Wednesday. The firm has a market cap of $20.49 million, a P/E ratio of -1.82 and a beta of 0.95. NanoViricides, Inc. has a twelve month low of $0.94 and a twelve month high of $3.59. The firm’s 50 day moving average price is $1.24 and its two-hundred day moving average price is $1.32.

NanoViricides Company Profile

NanoViricides, Inc, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-CoV-2, nanoviricide drug which is in phase 1a/1b clinical trails for the treatment of Covid; and NV-CoV-2 Oral Syrup, and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric cases.